Category: Issue Alert

Buzzfeed Quiz: Rising drug prices – Test your knowledge

Think you know high drug prices are rising? Try your hand at this Buzzfeed quiz and find out how serious the problem really is. Continue reading

Posted in: Health Care Costs, Issue Alert

That Time Pharma Companies Projected the Cost of Developing a Drug and Everyone LOL’d

2.6 billion dollars. That’s how much drugmakers would have people believe it costs to develop a single therapy. It’s the number that the Tufts Center for the Study of Drug Development released this week, presumably in an attempt to explain the skyrocketing prices being charged for many prescription drugs. Continue reading

Posted in: Health Care Costs, Issue Alert

Actuaries: High-cost meds threaten Medicaid’s ability to deliver quality, affordable care

In a recent analysis, the American Academy of Actuaries warns of a high-cost issue threatening Medicaid’s ability to balance access, quality, and affordability. The high-cost issue is the unsustainable price of breakthrough medications, like $1,000-a-pill Sovaldi. Continue reading

Posted in: Health Care Costs, Issue Alert

Newsweek: Drugmakers keep patients, doctors in the dark

What happens when so-called medical innovation involves suppressing science? That’s the question Newsweek asks in its latest cover story on clinical trials and the risks posed to patients when clinical reporting data reflects only a small glimpse of the results. Continue reading

Posted in: Health Care Costs, Issue Alert

It’s the R&D Costs? Really?

“The drug companies have to put a price on a medicine that reflects the cost of developing them, which is very expensive and takes a long period of time, and the value that it can provide.” Oh, really? “The cost of developing them.” That’s why drugs are so expensive? Really? Continue reading

Posted in: Health Care Costs, Issue Alert

Letter to the editor: Where’s the drug pricing transparency?

The astronomical price tag for a hepatitis C treatment highlights a major problem plaguing our health care system and its patients: a lack of transparency around pharmaceutical price setting, as noted in a Washington Post letter to the editor from Laura Worby, a primary care nurse practitioner. Continue reading

Posted in: Health Care Costs, Issue Alert

Mountain of evidence: Provider consolidation won’t lower costs

Health care stakeholders all are looking for ways to keep costs affordable and enhance the quality of care delivered to patients. Provider consolidation will not get us there. Continue reading

Posted in: Health Care Costs, Issue Alert

The value of provider networks

Consumers shopping for coverage will find that health plans offer a range of provider network choices. Understanding the value of provider networks is important, especially as consumers enroll in or change plans during Open Enrollment. Continue reading

Posted in: Issue Alert

How to solve the cancer care cost crisis

The nonpartisan Alliance for Health Reform and WellPoint today held an event that looked at cancer care–which costs about $125 billion a year–and whether new delivery reforms can lead to better care at lower costs for cancer patients. Continue reading

Posted in: Health Care Costs, Issue Alert, Uncategorized

On the Horizon: A Decision About Medicare Advantage Funding

As the political landscape changes in Washington, The Washington Post’s Wonkblog notes that Medicare Advantage and the 15 million Americans who rely on the program could find additional support among the newly elected members of Congress. But the Wonkblog article also serves to remind us that harmful cuts to Medicare Advantage are still scheduled in the coming years. Continue reading

Posted in: Issue Alert